CONMED (CNMD) PT Raised to $58 at Needham & Company Following 3Q Report

November 3, 2017 8:29 AM

Needham & Company raised its price target on CONMED (NASDAQ: CNMD) to $58.00 (from $57.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found